Journal
TRANSLATIONAL RESEARCH
Volume 179, Issue -, Pages 24-37Publisher
ELSEVIER SCIENCE INC
DOI: 10.1016/j.trsl.2016.04.007
Keywords
-
Categories
Funding
- National Institutes of Health [1R01DK073665-01A1, 1U01DK099924-01, 1U01DK099914-01]
- NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [U01DK099924, U01DK099914, R01DK073665] Funding Source: NIH RePORTER
Ask authors/readers for more resources
More than 100 trillion microbial cells that reside in the human gut heavily influence nutrition, metabolism, and immune function of the host. Gut dysbiosis, seen commonly in patients with chronic kidney disease (CKD), results from qualitative and quantitative changes in host microbiome profile and disruption of gut barrier function. Alterations in gut microbiota and a myriad of host responses have been implicated in progression of CKD, increased cardiovascular risk, uremic toxicity, and inflammation. We present a discussion of dysbiosis, various uremic toxins produced from dysbiotic gut microbiome, and their roles in CKD progression and complications. We also review the gut microbiome in renal transplant, highlighting the role of commensal microbes in alteration of immune responses to transplantation, and conclude with therapeutic interventions that aim to restore intestinal dysbiosis.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available